June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Pediatric thyroid eye disease: A 5-year review of clinical presentation, management, and outcomes at a single tertiary care center
Author Affiliations & Notes
  • Valerie Chen
    Ophthalmology, Emory University, Atlanta, Georgia, United States
  • Patrick Frias
    Ophthalmology, Emory University, Atlanta, Georgia, United States
  • Hee Joon Kim
    Ophthalmology, Emory University, Atlanta, Georgia, United States
  • Footnotes
    Commercial Relationships   Valerie Chen, None; Patrick Frias, None; Hee Kim, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 5163. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Valerie Chen, Patrick Frias, Hee Joon Kim; Pediatric thyroid eye disease: A 5-year review of clinical presentation, management, and outcomes at a single tertiary care center. Invest. Ophthalmol. Vis. Sci. 2017;58(8):5163.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose :
To summarize the clinical findings, treatments, outcomes, and complications for pediatric patients with thyroid eye disease in a single tertiary care center

Methods : A retrospective chart review was performed for pediatric patients (<18 years old) treated for thyroid eye disease at Emory University Hospital and Children's Healthcare of Atlanta between January 1, 2010 and December 31, 2015. Charts were reviewed for demographics, medical history, presenting symptoms, clinical exam findings, laboratory results, imaging studies, treatments, and outcomes.

Results : Twenty five pediatric patients with thyroid eye disease met criteria and were included in the study. Average age at diagnosis was 12.8 years (range 5-18 years). There was a heavy female predominance (92%). Twenty three patients (92%) were hyperthyroid on presentation. Prescribed medications included methimazole (96%), beta blockers (60%), and levothyroxine (60%). Other treatments included radioactive iodine (20%) and thryoidectomy (40%). The averate presenting visual acuity was logMar 0.055 (20/23 equivalent). There was abnormal motility on presentation in 8%. Upper lid retraction was present in 48% and lower lid retraction in 44%. Surgical decompression was performed in 1 (4%) patient. Lid retraction repair was performed in 2 (8%). No patient required strabismus surgery.

Conclusions : While thyroid eye disease tends to be more mild in the pediatric population and can often regress after treatment of thryoid dysfunction, surgical intervention may still be necessary to prevent complications and sight-threatening sequelae.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×